U.S. House · 119th Congress · H.R. 10628
Biosimilars Access and Affordability Act
To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Nicholas A. LangworthyR-NY-23
- Introduced
- September 28, 2026, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (9)
6 Democrats, 3 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Jake AuchinclossD-MA-4
- John JoyceR-PA-13
- Nathaniel MoranR-TX-1
- Kevin MullinD-CA-15
- Jimmy PanettaD-CA-19
- Scott H. PetersD-CA-50
- Linda T. SánchezD-CA-38
- Rudy Yakym IIIR-IN-2
Signed on later
- Donald G. DavisD-NC-1October 22, 2026